The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 27, 2018
Filed:
Nov. 02, 2015
Applicant:
Raqualia Pharma Inc., Aichi, JP;
Inventors:
Yasuhiro Iwata, Aichi, JP;
Kiyoshi Kawamura, Aichi, JP;
Masaki Sudo, Aichi, JP;
Kaoru Shimada, Aichi, JP;
Shinichi Koizumi, Aichi, JP;
Nobuyuki Takahashi, Aichi, JP;
Keiko Obata, Aichi, JP;
Makiko Kuroda, Aichi, JP;
Assignee:
RaQualia Pharma Inc., Aichi, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/14 (2006.01); A61K 31/437 (2006.01); A61K 31/444 (2006.01); A61K 45/06 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/444 (2013.01); A61K 45/06 (2013.01); C07D 471/04 (2013.01); A61K 2300/00 (2013.01);
Abstract
The present invention relates to novel compounds of a formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes for their preparation, pharmaceutical compositions comprising them and their use in therapy, for example as modulators of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSR-1a receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.